EGFR and hepatocellular carcinoma: Several components of signaling pathways, such as RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, VEGF/ VEGFR, EGF/EGFR, etc. are promising targets in HCC [18, 22, 23].